Sterigenics International, a leading global provider of outsourced contract sterilisation services and a portfolio company of GTCR, has announced it has completed its $826 million acquisition of Nordion.
"We are incredibly excited to welcome the Nordion employees to the global Sterigenics team," said Michael Mulhern, Sterigenics International CEO. "For more than 30 years, we have known the Nordion organisation and have deep respect and appreciation for their people and expertise. By completing this acquisition, we are creating the only vertically integrated sterilisation company in the world and will have a broader product portfolio, service offering and global footprint to better serve customers worldwide. Moving forward, Sterigenics is extremely well positioned to build on its mission of improving global public health."
As a standalone business within Sterigenics, Nordion will remain headquartered in Ottawa, Canada and will continue to operate under the Nordion name.
